Institutional Career Development Core
Institutional Career Development Core
批准号:
10627344
负责人:
Bo Liu
金额:
$103.8万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-21 至 2027-06-30
关键词:
AddressAreaAttentionClinicalClinical ResearchCommunitiesDisciplineDissemination and ImplementationEcosystemEthnic OriginEthnic groupFamilyFosteringFundingGrantGuidelinesHealthIndividualIndustryInstitutesJournalsLeadershipLifeMeasuresMentorsMentorshipNeeds AssessmentOutcomeParticipantPatientsPositioning AttributePrincipal InvestigatorProgram EvaluationPublishingRaceResearchResearch DesignResearch PersonnelScienceScientistSecureStrategic PlanningTrainingTranslational ResearchUniversitiesVisionWisconsinWomanWorkcareercareer developmentclinical carecommunity engagementdesignhealth equityimprovedinnovationinter-institutionalmemberprogramsrecruitresearch data disseminationresiliencestressorsuccesstranslational pipeline
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Contact PD/PI: Brasier, Allan Inst-Career-Dev-001 (002)
INSTITUTIONAL CAREER DEVELOPMENT CORE (KL2) ABSTRACT. The University of Wisconsin (UW)
Institute for Clinical and Translational Research (ICTR) KL2 Program, launched in 2007, has recruited and
trained 82 scholars (55% women, 14% underrepresented race/ethnicity) varied in their identities, discipline,
area of study, and position along the translational spectrum. We appoint three scholars per year for four years
using a combination of internal and external funds. Graduated scholars remain committed to research (90%) in
academics or industry, have been promoted or are eligible for promotion (87%), have successfully competed
for funding as a principal investigator/multiple principal investigator ($225 million) and as a co-investigator
($288 million), and have published prolifically as first/senior author (513) and as a co-author (1,456). In order to
accelerate these and other successes, ICTR has completed an institute-wide strategic plan (Innovation
Scorecard) that serves as a roadmap to use continuous improvement to address ongoing challenges in
conducting efficient, rigorous, and engaged CTR at our Hub—with specific attention to CTR capacity building.
In concert with these continuous program improvement efforts, we engaged a comprehensive KL2 needs
assessment, which recognized key challenges to early-career scientists, including: 1) maintaining work-life
integration, 2) transitioning to independence, 3) promoting diversity in research teams and study participants,
4) designing research for dissemination, and 5) disseminating and implementing research to improve health
outcomes. In the next grant period, we propose to refine our KL2 Program to address these challenges by
achieving the following Specific Aims: 1) Enhance scholar’s vitality by building their capacity to adjust to life
and career stressors, 2) Foster scholars’ engagement of community members in research conduct and
dissemination, 3) Establish longitudinal programming to help scholars incorporate dissemination and
implementation concepts into their research programs, and 4) Disseminate the KL2 Program’s mentorship and
coaching innovations. We have developed a comprehensive plan to increase the recruitment and retention of
scholars from historically underrepresented racial and ethnic groups. We have also designed a rigorous
program evaluation plan to assess influence at all levels of the translational research ecosystem. Program
success will be measured at each level: 1) individual: secure grants and publish work in high-impact journals;
2) proximal: develop and maintain relationships with mentors, mentees, and research teams; 3) institutional
and inter-institutional: form inter-disciplinary scientific teams and transform clinical care and institutional
culture; and 4) societal: revolutionize clinical guidelines and improve health and health equity. The KL2
leadership team’s innovative vision of program enhancement in the areas of mentorship, team science,
leadership, dissemination and implementation, and career resilience will foster and launch a cadre of diverse,
independently funded leaders of CTR who will impact the health of our patients, families, and communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Role of Thrombospondin-1 in Protection against Rupture of Abdominal Aortic Aneurysm
-
批准号:10383732
-
项目类别:
-
资助金额:$45.99万
-
财政年份:2021
-
负责人:Bo Liu
-
依托单位:
Novel Role of Thrombospondin-1 in Protection against Rupture of Abdominal Aortic Aneurysm
-
批准号:10609876
-
项目类别:
-
资助金额:$45.99万
-
财政年份:2021
-
负责人:Bo Liu
-
依托单位:
Role of RIP3-laden extracellular vesicles in thrombosis and aortic aneurysm
-
批准号:10630195
-
项目类别:
-
资助金额:$47.28万
-
财政年份:2020
-
负责人:Bo Liu
-
依托单位:
Role of RIP3-laden extracellular vesicles in thrombosis and aortic aneurysm
-
批准号:10414974
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2020
-
负责人:Bo Liu
-
依托单位:
Role of RIP3-laden extracellular vesicles in thrombosis and aortic aneurysm
-
批准号:10214685
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2020
-
负责人:Bo Liu
-
依托单位:
Engineered Models of Diseased Heart Valves to Study Sex Bias in Disease Progression
-
批准号:10317066
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2019
-
负责人:Bo Liu
-
依托单位:
Institutional Career Development Core
-
批准号:10673208
-
项目类别:
-
资助金额:$103.8万
-
财政年份:2017
-
负责人:Bo Liu
-
依托单位:
Vascular smooth muscle cell apoptosis in intimal hyperplasia
-
批准号:9266463
-
项目类别:
-
资助金额:$44.07万
-
财政年份:2015
-
负责人:Bo Liu
-
依托单位:
Vascular smooth muscle cell apoptosis in intimal hyperplasia
-
批准号:9110305
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2015
-
负责人:Bo Liu
-
依托单位:
Molecular mechanisms in Abdominal Aortic Aneuysm
-
批准号:8399030
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2010
-
负责人:Bo Liu
-
依托单位:
Molecular mechanisms in Abdominal Aortic Aneuysm
-
批准号:8576467
-
项目类别:
-
资助金额:$43.36万
-
财政年份:2010
-
负责人:Bo Liu
-
依托单位:
Molecular Mechanisms in Abdominal Aortic Aneuysm
-
批准号:9899284
-
项目类别:
-
资助金额:$45.74万
-
财政年份:2010
-
负责人:Bo Liu
-
依托单位:
Molecular mechanisms in Abdominal Aortic Aneuysm
-
批准号:8040544
-
项目类别:
-
资助金额:$47.62万
-
财政年份:2010
-
负责人:Bo Liu
-
依托单位:
Molecular mechanisms in Abdominal Aortic Aneuysm
-
批准号:8206613
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2010
-
负责人:Bo Liu
-
依托单位:
PKC-Delta in Intimal Hyperplasia after Vascular Bypass
-
批准号:7468499
-
项目类别:
-
资助金额:$11.64万
-
财政年份:2005
-
负责人:Bo Liu
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: